¹B°Ê¥Í²z¶g°T(²Ä400´Á)
°ªÄÖ°I®zªÌªº¹B°Ê«ü¾É»P«ØÄ³(November 25, 2019)
¤è¶i¶©¡@¥xÆW®v½d¤j¾Ç¦WÅA±Ð±Â
³ü¡B«e¨¥
¡@¡@°I®z¡Bµê®z©ÎÅé®z (^¤åfrail§Î®eµü©Îfrailty¦Wµü)¡A³o¨Ç¦Wµüªº¤¤¤å·N²[«Ü±µªñ¡A±`³Q¤¬¥Î¡C°I®z¬O«ü¨Åé³B¦bµê®zª¬ºA¡A¥¦»P°ªÄÖ¡B¯e¯f©M¨Åé¥\¯à (physical function) µ¥¦]¯À¦³Ãö¡A¦~¬ö¶V¤j¡A¨Åéµê®zªº²±¦æ²v¶V¤j¡A¦p¨S¦³¥[¥Hª`·N©M§ïµ½¡Aµê®z±¡ªp±NÄ~Äò´c¤Æ¡A ¹J¨ì¤º¥~¦bªºÀ£¤O©Î¬D¾Ô±¡ªp®É¡A´N¸û®e©öµo¥Í¶^Ë¡B¥¢¯à¡Bª×§É¡B¦í°|¬Æ¦Ü¦º¤`ªº±¡§Î¡C
¡@¡@°I®z»P¨Åé¥\¯à¦³±K¤ÁÃö«Y¡A¾ÇªÌ¨Ì¾Ú°ªÄ֪̪º¨Åé¥\¯à¤À¦¨¤¤jÃþ¡G1. ¨Åé¨Ì¿à (physically dependent)¡B2. ¨Åé°I®z (physically frail)¡B3. ¨Åé¿W¥ß (physically independent)¡B4. ¨Åé¨}¦n (physically fit)¡B5. ¨ÅéÀu²§ (physically elite)¡A¨ä¤¤¦³30%ªº°ªÄ֪̳B©ó¨Åé°I®z©M¨Ì¿àªºª¬ºA (Spirduso, et al., 2005)¡C°I®zªÌ¤¶©ó¨Åé¿W¥ß©M¨Ì¿à¤§¶¡¡A©|¥i±q¨Æ°ò¥»ªº¤é±`¬¡°Ê©M»´ÃP®a°È¡A¦³¨Ç¤H¦b²¾°Ê¨Åé®É©Î³\»Ýn¨ó§U¡A¦ý¥L̳B¦b¥¢¯àªº°ª·ÀIª¬ºA¡A®e©ö°I°h¦Ó¥¢¯à¡C
¡@¡@¥Ø«e¹ï©óµê®zªÌ¨Ã¨S¦³©ú½Tªº§ïµ½¤èªk¡A¦ý´£¤É¡u¨Åé¥\¯à ¡v±N¬O¥¼¨Ó«nµ¦²¤ (WHO, 2015; U.S. Department of Health and Human Service, 2018)¡A¦Ó³W«ß¹B°Ê©Î°ÊºA¥Í¬¡¤è¦¡¬O³Q±ÀÂ˪º¦³®Ä¤èªk (U.S. Department of Health and Human Service, 2018; Best-Martini & Jone-DiGenova, 2014; American Heart Association, 2007)¡C¥»¤å¾ã²z¬ÛÃöªº¬ã¨s©M¸ê®Æ¡A°w¹ï°ªÄÖ°I®zªÌªºµû¶q¤èªk¡B¹B°Ê¯q³B¡B¹B°Ê«ü¾É¤@¯ëì«h©M¹B°Ê³B¤èªº³]p»P«ØÄ³µ¥±¦V¥[¥H±Ôz¡A§Æ±æ´£¨Ñµê®zªÌ¡B¨ä®a¤H¡BÂåÅ@¤Hû©ÎÅé¾A¯à«ü¾Éû¹ê¥Îªº¸ê°T»P«ØÄ³¡A´Á¬ß¹ïµê®zªÌªº°·±d«P¶i¦³©Ò§U¯q¡C
¶L¡B¨Åéµê®zµû¶q¤èªk
¡@¡@¤@½gºî¾ã¬ã¨s (review) «ü¥X¡A65·³¥H¤WªÀ°Ï¦Ñ¦~¤Hªºµê®z²±¦æ²v¬ù¦³10.7% (4-17%)¡A¦Ó«eµê®zªÌ (Prefrail) ²±¦æ²v¦³41.6% (38-53%) (Collard, et al., 2012)¡C¦b¥xÆWªÀ°Ï65·³¥H¤W¦Ñ¦~µê®zªº²±¦æ²v¬ù11-14.9% (Chang, et al., 2011)¡Cµê®zªºµû¶q»P§PÂ_¤èªk«Ü¦h¡A°ò¥»¤W·|¦Ò¶q¦hÓ¼h±¡A¦ý¤£¥]¬A¯e¯f»P¥¢¯à±ø¥ó¡A¥Ø«eFriedµ¥ (2001) ©M¼Ú¬wÃÄ«~ºÞ²z§½ (European Medicines Agency, 2015) ´£¥Xªº¨Åéªí²{ (Physical performance) ´úÅç¸û±`³Q¨Ï¥Î¡C
¤@¡B¬ü°ê±Ä¥Îªº¤èªk
¡@¡@Friedµ¥¤H (2001) ¦Ò¶q¤Ó±¦V¨Óµû¶q¨Åéµê®z¡A¥]¬A¡G
1. Åé«´î»´¡G1¦~¤º´î»´10½S (¬ù4.5¤½¤ç) ¥H¤W¡Aªí¥Ü¦Ù¦×µäÁY©Î¦³¦Ù¤Ö¯g¡C
2. µê®z (weakness)¡G´¤¤O (¦Ù¤O) ´î®z¡A§C©ó¦P©Ê§O©M¦~ÄÖ20%¦Ê¤Àµ¥¯Å (¦P©Ê§O©M¦~Ä֪̤¤´¤¤O§C©ó20%µ¥¯Å)¡C
3. ¯h¾Î (exhaustion) (¦Û¤v·Pı¯h¾ÎµL¤O)¡C
4. ²¾°Ê½wºC (slowness) : 15 feet (¬ù4.5¤½¤Ø) ªº¨«¸ô³t«×§C©ó¦P©Ê§O©M¦~ÄÖ20%µ¥¯Å¡C
5. ¨Å鬡°Ê¤Ö¡G¨C¶g¨k©Ê§C©ó383¤j¥d¡B¤k©Ê§C©ó 270¤j¥d (§C©ó¦P©Ê§O©M¦~ÄÖªÌ20%µ¥¯Å)¡C
µê®z (frail)¡G«ü¤Wz 5Ó¶µ¥Ø¤¤¦³3Ó¶µ¥Ø¥H¤W¨S¹F¨ì¼Ð·Ç¡C«eµê®z (prefrail)¡G«ü5Ó¶µ¥Ø¤¤¦³1©Î2Ó¶µ¥Ø¨S¹F¨ì¼Ð·Ç¡C
¡@¡@¥xÆW¾ÇªÌ±Ä¥ÎFriedµ¥¤Hªº¤èªk¿î¿ïµê®z»P«eµê®z°ªÄ̡֪A±q¨Æ¹B°Ê¤¶¤Jªº¬ã¨s¡A¦b¤Ó¶µ¥Ø¤¤¡A¦³¨Ç¶µ¥Øªº¼Ð·Çµy¦³×¥¿¡A¦ý¦³¸û©ú½Tªº±Ôz¥i¥H¨Ñ§PÂ_°Ñ¦Ò (Liao, et al., 2019)¡A¦p¡G1. Åé«´î»´¡G3Ӥ뤺´î»´Åé«1.5 Kg (¤£¬O¦³·N¹Ï´î«)¡C2. µê®z¡G¥HºD¥Î¤â¦b´¤¤O¾¹´úÅç3¦¸¦Ù¤O¡A3¦¸¥§¡È¬°´¤¤O§PÂ_¨Ì¾Ú¡C¨k©Ê¦pBMIÈ ≤ 24¡B´¤¤O§C©ó ≤ 29 kg; BMIÈ 24.1-28¡B´¤¤O§C©ó ≤ 30 kg; BMIÈ > 28¡B´¤¤O ≤ 32 kg¡F¤k©Ê¦pBMIÈ ≤ 23¡B´¤¤O ≤ 17 kg; BMIÈ 23.1-26¡B´¤¤O ≤ 17.3 kg; BMIÈ 26.1-29¡B´¤¤O ≤ 18 kg; BMIÈ > 29¡B´¤¤O≤ 21 kg¡C3. ¯h¾Î (exhaustion)¡G¦b¨âÓ°ÝÃD¤¤¦³¤@ÃD¥H¤W²Å¦X¡A¡u§Úı±o«Ü²Ö¦ÓµLªk°µ¥ô¦ó¨Æ±¡¡v©Î¡u§Ú¯Ê¥F°Ê¾÷¥h°µ¥ô¦ó¨Æ±¡¡v¡C4. ²¾°Ê½wºC (slowness)¡G4.57¤½¤Øªº¥®É¨«¸ô®É¶¡¶W¹L¤U¦C¼Ð·Ç¡C¨k©Ê¨°ª173 cm¥H¤W¡B¶W¹L 6 ¬í¡A¨°ª173 cm¥H¤U¡B¶W¹L 7 ¬í¡C¤k©Ê¨°ª159¤½¤À¥H¤W¡B¶W¹L 6 ¬í¡A¨°ª159¤½¤À¥H¤U¡B¶W¹L 7 ¬í¡C5. ¨Å鬡°Ê¤Ö¡G¥Hµuª©ªº°ê»Ú¨Å鬡°Ê°Ý¨÷ (International Physical Activity Questionnaire , IPAQ) ½Õ¬d¨Å鬡°Ê¶q¡A¨C¶g¨k©Ê§C©ó594¤j¥d¡A¤k©Ê§C©ó 295¤j¥d¬°§PÂ_¨Ì¾Ú¡C
¤G¡B¼Ú¬wÃÄ«~ºÞ²z§½¤§¨Åéªí²{ (physical performance) µû¶q¤èªk
¡@¡@¼Ú¬wÃÄ«~ºÞ²z§½ (European Medicines Agency, 2015) »{¬°¨Åéµê®zµû¶q¤èªkn¦Ò¶q¤U¦C±ø¥ó¡A¥]¬A¡G1. ¦³¹w´ú¥¢¯à»P¦º¤`¥\¯à¡C2. ¦³®Ä«×¡C3. Á{§É¥i¥HÀ³¥Î¡C4. ®e©ö´ú¶q¡C5. µû¶q®É¶¡¡C6. »ù¿ú¡C7. ¬ã¨s°V½m¨Ï¥Î®e©ö¡C¦]¦¹¡A¦b¦Ò¶q³o¨Ç±ø¥ó©M¬ÛÃö¤åÄm«á¡A «ØÄ³¥H´ú¶q¨Åéªí²{¨Óµû¦ô¨Åéµê®z¡A¥Dnªº´ú¶q¶µ¥Ø¦³¥¿Å¡B¨«¸ô³t«×©M§¤¯¸´úÅç¡A¨CÓ¶µ¥Ø³Ì¦h 4 ¤À (0-4¤À)¡C
¡@¡@³o 3 Ó´úÅ窺¤èªk©Mµ¹¤À¤è¦¡»¡©ú©ó¤U¡C
(¤@) ¥¿Å´úÅç¡G3 ºØ«º¶Õ¥¿Å´úÅç©Mµ¹¤À¡C1. Âù¸}¦X¨Ö¯¸¥ß (side-by-side stand) 10¬í¡GÂù¸}¾a¦b¤@°_¯¸¥ß¡C®É¶¡§C©ó10¬í0¤À¡B10¬í1¤À¡C2. ¤@¸}©ñ¦b¥t¤@¸}¤¤¶¡¤º°¼¯¸¥ß (Semi-tanden stand) 10¬í¡C¯¸¥ß®É¶¡§C©ó10¬í0¤À¡B10¬í1¤À¡C3. ¤@¸}¸ò©ñ¦b¥t¤@¸}«e¤è¯¸¥ß (Tanden stand) 10¬í¡C¯¸¥ß®É¶¡§C©ó3¬í0¤À¡B3-9.99¬í1¤À¡B10¬í2¤À¡C
(¤G) ¨«¸ô³t«×´úÅç¡G¥H¥±`¨«¸ô³t«×¨«¥|¤½¤Ø¡A¨«¨â¦¸¡A¨ú³Ì¨Î¦¨ÁZ¡C<4.82¬í4¤À¡B4.82-6.20¬í3¤À¡B6.21-8.70¬í2¤À¡B> 8.7¬í1¤À¡B¤£¯à¨«0¤À¡C
(¤T) §¤¯¸´úÅç¡G¨ü´úªÌÂù¤â¥æ¤e©ó¯Ý«e¡A¹Á¸Õ¥Ñ´È¤l¯¸¥ß¤@¦¸¡C¤£¯à¯¸¥ß¡G0¤À¡B¯à°÷¯¸¥ß¡G´ú¶q¥Ñ´È¤l¯¸¥ß¦A§¤¤U¡A¯¸¥ß®ÉÂù¸}n®¼ª½¡A¤]¤£¯à¥ÎÂù¤â¤ä¼µ¡C¨ü´úªÌnºÉ§Ö§¹¦¨ 5¦¸§¤¯¸¡A°O¿ý¤ÏÂÐ 5¦¸ªº®É¶¡¡A¨Ì®É¶¡§ÖºCµ¹¤À¡C<11.19¬í4¤À¡B11.20-13.69¬í3¤À¡B13.70-16.69¬í2¤À¡B>16.7¬í1¤À¡B>60¬í©Î¤£¯à¯¸¥ß 0¤À¡C
µê®zµ¥¯Å§PÂ_¡G¨CÓ´ú¶q¶µ¥Ø³Ì°ª4¤À¡A3Ó¶µ¥Ø³Ì°ª12¤À¡AÁ`¤À¤¶©ó0-12¤À¡C10-12¤À¬°¥¿±`ªÌ¡B8-9¤À¬°«eµê®zªÌ¡B§C©ó7¤À¬°µê®zªÌ
¡@¡@¼Ú¬wÃÄ«~ºÞ²z§½»{¬°Friedµ¥¤H (2001) ªº¬ã¨s¹ï¶H¦í¦bªÀ°Ï¡A¥h°£»{ª¾¤£¨Î¡B¼~Æ{¡B¤¤·©M¤Úª÷´Ëªº°ªÄ̡֪A³oÓµû¶q¤èªkn¦bÁ{§É¤WÀ³¥Î¡A·|²£¥Í¤@¨Ç§xÃø¡A¦pn§Q¥Î°Ý¨÷µû¶q¸ß°Ý±wªÌ¨C¶gªº¨Å鬡°Ê¡A¦Ó¥B¥¦¤ñ¨Åéªí²{µû¶q¤èªk»Ýn§ó¦h´ú¶q®É¶¡¡B¾¹§÷©M±M·~ª¾¯à¡C
¡@¡@¾ÇªÌ (Verghese ¡® Xue, 2010) ¥H¨Åéªí²{´úÅç (Physical performance battery, PPB) §@¬°¦Ñ¦~¤Hµê®zµ{«×ªº§PÂ_¨Ì¾Ú¡A¨Ã©MFried et al., (2001) ªºµû¦ô¤èªk°µ¤ñ¸û¡Aµ²ªGÅã¥ÜPPBªº¤TºØ´úÅç (¥¿Å¡B¨«¸ô³t«×©M§¤¯¸) ¦¨ÁZ©M¨Åéµê®z§P§O¤À¼Æ (Fried, et al., 2001) ¦³ÅãµÛ¬ÛÃö¡C¥LÌ¥H539¦ì¬¡°Ê¥¿±`ªº¦Ñ¦~¤H¬°¬ã¨s¹ï¶H¡A±Æ°£ª×§É¡BÄY«Å¥µøÄ±»Ùê¡B¨BºA½wºC¡B¥¢´¼©M¥¢¯à°ªÄ̡֪C¬ã¨s¹ï¶H±µ¨üµê®zµû¦ô©MPPB¨âºØ´ú¶q«á¡Aµo²{¦³106¦ì (19.7%) ¬Oµê®zªÌ¡A¨ä¥L433¦ì¤£¬Oµê®zªÌ¡A¨â²Õ¦Ñ¦~¤H¤ñ¸û«áÅã¥Ü¡Aµê®z¦Ñ¦~¤Hªº´¤¤O¡B¨«¸ô³t«×©Mµê®zµ¥¯Å¤À¼Æ¬ÒÅãµÛ¤ñ¤£µê®zªÌ®t©Î¤£¦n¡A¦Ó¥BPPB ªº¤À¼Æ¤]¸û§C (0-12¤À¡A¤À¼Æ¶V°ª¶V¦n)¡C
°Ñ¡B¹B°Ê°V½m©Î³W«ß¨Å鬡°Êªº¯q³B
¡@¡@¹L¥h¦³Ãö¹B°Ê°V½m©Î³W«ß¨Å鬡°Ê§ïµ½¦Ñ¦~¤Hµê®z¯gªº¬ã¨s¨Ã¤£¦h¡A¯÷±N´X½g³Ìªñ¬ÛÃö¬ã¨s©Î¤åÄmªºµ²ªG©M¯q³B±Ôz¦p¤U¡C
¡@¡@Haiderµ¥ (2019) ¥H±Ôzºî¾ã¤åÄm (narrative review) ¤è¦¡¡A¦¬´MÀH¾÷¤À¬£ªº½×¤å¡A±´°Q¨Å鬡°Ê¤¶¤J©Î°V½m¹ï©óªÀ°Ïµê®z©M«eµê®z°ªÄ֪̪º®ÄªG¡C ¨Å鬡°Ê¤¶¤J¤è¦¡¥]¬A¦³®ñ¹B°Ê¡Bªý¤O°V½m¡B¥¿Å°V½m©Mµ²¦X°V½m (µ²¦Xªý¤O¡B¦³®ñ©Î¥¿Å°V½m) µ¥¹B°Ê°V½m¤èªk¡AÁ`¦@14½g½×¤å²Å¦X³o¨Ç±ø¥ó¡A¦ý³o¨Ç½×¤åªº¨Å鬡°Ê¤¶¤J¤è¦¡«Ü¦h¤¸¡A°V½m¤è¦¡¡B¹B°Ê±j«×¡B«ùÄò®É¶¡¡B°V½m´Á©Îµû¶q¤è¦¡µ¥³£¤£¤@¼Ë¡A«ü¾É¨Å鬡°Ê¤¶¤Jªº¤Hû©Î°V½m³õ©Ò¤]¤£¬Û¦P¡A¦³°·±d±M·~¤Hû©Î§Ó¤u±a»â¹B°Ê¡A¦³ªº¦b®a°V½m©Î¬O¦b°·±d·ÓÅ@¾÷ºc¹B°Ê¡Cµ²ªG¡GÁöµM¡A¨Å鬡°Ê¤¶¤Jªº¬ã¨s¤£¦h¡A¹B°Ê°V½mªº¤è¦¡©Mµ²ªG¤]¤£«Ü¤@P¡A¦ý©M±±¨î²Õ¤ñ¸û¡A°Ñ»P¨Å鬡°Ê¤¶¤JªºªÀ°Ïµê®z¦Ñ¦~¤H¥i¥HÅãµÛ§ïµ½µê®zª¬ºA (frailty status)¡A¤]´£¤É¦Ù¤O©M¨Åéªí²{ (physical performance)¡C
¡@¡@Liaoµ¥ (2019) ±´°Q12¶g¹B°Ê°V½m©Î°ÊºA¹CÀ¸°V½m¹ï©ó°ªÄÖµê®z«ü¼Ðªº®ÄªG¡A¥L̼x¨DªÀ°Ï¦Ñ¦~¤H¬°¬ã¨s¹ï¶H¡A¦@¦³52¦ì65·³¥H¤W²Å¦X«eµê®z©Îµê®zªÌ°Ñ»P³o¤¶¤Jpµe¡A°Ñ»PªÌ³QÀH¾÷¤À¬£¬°¹B°Ê°V½m²Õ (µ²¦X¦³®ñ¡Bªý¤O©M¥¿Å°V½m) ©M°ÊºA¹CÀ¸²Õ (Exergaming, n²¾°Ê¨Å骺¹q¸£¹CÀ¸) ¨â²Õ¡C¹B°Ê°V½m²Õ©M°ÊºA¹CÀ¸²Õªº°Ñ»PªÌ±µ¨ü12¶g¡A¨C¶g¤T¤Ñ¡A¨C¤Ñ¤@¤p®É¡A¦@36¦¸ªº°V½m¡A¨Ã©ó¨Å鬡°Ê¤¶¤J«e«á±µ¨üµê®z«ü¼Ð©Î¨Åé¥\¯àªº´úÅç©Îµû¶q¡C¹B°Ê°V½m²Õªº¤¶¤J°V½m¤º®e»P¤èªk¨Ì¾Ú¬ü°ê¹B°ÊÂå¾Ç·| (American College of Sports Medicine, ACSM) ªº«ü¾Éì«h³]p¡A¨C¦¸¤@¤p®Éªº¹B°Ê¥]¬Aªý¤O¹B°Ê¡B¦³®ñ¹B°Ê©M¥¿Å¹B°Ê¦U20¤ÀÄÁ¡C °ÊºA¹CÀ¸²Õ§Q¥Î¹q¸£°ÊºA¹CÀ¸¨t²Î (Kinect systems, Microsoft Corporation, Redmond, WA, USA)¡A¦b¹q¸£»È¹õ¤W¤Þ¾É°ªÄ֪̲¾°Ê¨Åé©Î¹B°Ê¡A¤º®e¥]¬A¤Ó·¥®±20¤À¡B¦³®ñ¹B°Ê»Pªý¤O¹B°Ê20¤ÀÄÁ©M¥¿Å¹B°Ê20¤ÀÄÁ¡Cµ²ªG¨âÓ°V½m²Õ©ó°V½m«á¬ÒÅãµÛ§ïµ½µê®zª¬ºA (frail status) ©Mµê®zªí²{«ü¼Ð¡A¦ý¨âÓ°V½m²Õ¤§¶¡¨S¦³ÅãµÛ®t²§¡C¦b¹B°Ê°V½m²Õ¤¤¡A¦³16¦ìµê®zªÌ¦b¤¶¤J«á¡A¦³6¦ìÂର«eµê®zªÌ¡A¦³9¦ì«eµê®zªÌ¡A¨ä¤¤¦³4¦ìÂର°·±d«ü¼Ðª¬ºA (¤¶µ«ü¼Ð¬Ò³q¹L)¡Cµê®zªí²{«ü¼Ð¤¤¦³¤TÓ¬Ò¦³©úÅ㪺§ïµ½¡A¥]¬A§ïµ½µê®z¡B¨«¸ô³t«×©M¼W¥[¨Å鬡°Ê¶q¡C
¡@¡@¬ü°ê°·±dªA°È³¡2018¦~¤½¥¬¡u¬ü°ê¨Å鬡°Ê«ü«n¡v«ü¥X¡A¹B°Ê°V½m¥H¤¤µ¥±j«×¥H¤Wªº¨Å鬡°Ê¡A¥]¬A¦hºØ¤è¦¡ªº°V½m (²[»\¦³®ñ¹B°Ê¡Bªý¤O°V½m¡B¥¿Å°V½m»P¦ù®i¾Þµ¥)¡A¨C¶g¤T¤Ñ¥H¤W¡A¨C¦¸°V½m®É¶¡30-45¤ÀÄÁ¡A«ùÄò¦Ü¤Ö3-5¤ëªº¹B°Ê°V½m¡A¥i¯à¬O´£¤Éµê®z¦Ñ¦~¤H¨Åé¥\¯àªº³Ì¦³®Äªº¤è¦¡¡A¦Ó¦hºØ¹B°Ê²Õ¦X¤è¦¡¤ñ³æ¤@¹B°Êªº°V½m®ÄªGÁÙ¦n¡Cµê®z¦Ñ¦~¤H±`¦³³\¦hºØºC©Ê¯e¯f¡A¤]®e©ö¥¢¯à¡A³W«ß¨Å鬡°Ê¬O¹w¨¾©MºÞ²z¦Ñ¦~¤HºC©Ê¯e¯fªºÃöÁä¡A¥B¥i¥H«O¦s¨Åé¥\¯à©M¬¡°Ê¯à¤O (U.S. Department of Health and Human Service, 2018)¡C
¡@¡@¡uµê®z¦Ñ¦~¤Hªº¹B°Ê¡vªº§@ªÌ (Best-Martini & Jone-DiGenova, 2014) «ü¥X¡A¤£ºÞ¦Ñ¦~¤Hªº°·±d»P»Ý¨Dª¬ªp¦p¦ó¡A³W«ß¨Å鬡°Ê¬Oºû«ù¥L̨Åé¥\¯à©M¿W¥ß³Ì¦nªº¤èªk¡A¬O´£¤Éµê®z°ªÄ̧֪ó¨Î°·±dª¬ªp©M¥Í¬¡«~½è©Ò¥²¶·¡C¾A«×¨Å鬡°Ê´N¥i¥H³y¦¨«¤jªº¥¿±§ïÅÜ¡A´î§Cµê®zªºµ{«×¡C¬ã¨s«ü¥X³W«ß¹B°Ê¥i§ïµ½¦Ù¤O¡B¦Ù@¤O¡B¥¿Å¡B¨ó½Õ©M¤ßªÍ¥\¯à¡A§Y¨Ï³o¨Ç¤H¦~¬ö«Ü¤j©Î¬O«D±`ªºµê®z¡C
¸v¡B¹B°Ê«ü¾Éªº¤@¯ëì«h
¡@¡@¥Ø«e°ê¤º¥~¨Ã¨S¦³©ú½Tªºµê®z¦Ñ¦~¤H¹B°Ê«ü¾Éì«h¡A¥»¤å°Ñ¦ÒACSM©M¬ÛÃöªº¦Ñ¦~¤Hªº¹B°Ê«ü¾É¸ê®Æ¡A¦Ò¶qµê®zªÌªºÓ§O®t²§»P»Ý¨D¡A¦A°µ¾A«×ªº×¥¿©Î½Õ¾ã¡A¥H´£¨Ñ¦w¥þ¦³®Äªº¹B°Êpµe¡A¦Ó´£¤É¨Åé¥\¯à©M§ïµ½µê®zµ{«×¡C¥H¤U´XÓ¹B°Ê«ü¾Éªº¤@¯ëì«h¡A¦b¹B°Ê«ü¾É®É¥i°Ñ¦ÒÀ³¥Î¡C
¤@¡B ¹B°Ê«en¦³¦w¥þµû¦ô
¡@¡@¤j³¡¤Àµê®z°ªÄ֪̦³¦n´XºØºC©Ê¯e¯f¡A¤]¸û¤Ö±q¨Æ³W«ß¹B°Ê¡A¦]¦¹¦b¹B°Ê©ÎÅé¾A¯àÀË´ú«e¡An°Ñ·ÓACSM (ACSM, 2018) ªº¦w¥þµû¦ô¨BÆJ»P«ØÄ³¡A¥ý½Ð±Ð°·±d·ÓÅ@¤Hû (§tÂå®v)¡AÀò±o¦P·N«á¦A±q¨Æ¹B°Ê¡A¦P®É¸ß°Ý¹B°Ê¬ÛÃö°ÝÃD¡A¦pn±q¨Æþ¨Ç¹B°Ê¡H¹B°Ê¦³þ¨Ç¯q³B¡H ¦p¦ó¦w¥þ±q¨Æ¹B°Ê¡H
¤G¡B ¦Ò¶q¹B°Ê¦w¥þ¡B¦w¥þ²Ä¤@
¡@¡@µê®zªÌ¹B°Ê®É¡AÀH®Énª`·N¦w¥þ¡A¤F¸Ñ¦Û¤vªºª¬ªp»P¨î¡A¤£n«j±j¹B°Ê¡CÅé¾A¯à±Ð½m©Î«ü¾ÉªÌn¤F¸Ñµê®zªÌ¦³¨º¨Ç¯e¯f¡B¨î©M¯S§O»Ý¨D¡A¦b¹B°Ê«ü¾É¤¤¤~¯àµ¹¤©¾A«×¨ó§U¡A¨Ãª`·N¦w¥þ¡C¹B°Ê®É¿í¦u¡uÅý¯kµh¤Þ¾É±z, Let pain be your guide¡vì«h¡A¦³¯kµh©Î¤£µÎªA®Én°±¤î¹B°Ê©Î´î»´¹B°Êt²ü¡C¹B°Ê®É¤]n¦Ò¶qÀô¹Ò¦w¥þ¡A¹³¿O¥ú (¥ú½un¨¬°÷)¡B¦a± (¬O§_Àã·Æ©Î¦³»Ùꪫ) ©M¤ä«ùª« (¥¢¥h¥¿Å®É¥i¥H¤ä¼µ) µ¥¡C
¤T¡B¤F¸Ñ¯e¯f»P¥ÎÃάªp
¡@¡@µê®z¦Ñ¦~¤H¬Û¹ïªº·|¦³³\¦hºC©Ê¯e¯f¤]ªA¥Î³\¦hÃĪ«¡C¥Ñ©ó¥NÁ¸ûºC¡AÃĪ«¯d¦b¨Å骺®É¶¡¸ûªø¡A¦Ó³o¨ÇÃĪ«¥i¯à³£¦³°Æ§@¥Î¡A¤j³¡¤ÀªºÃĪ«·|¦³·w¯t¡BÀY»´¡B²V¶Ãªºª¬ªp¡A¥i¯à·|¼vÅT¹B°Ê®Éªº¥¿Å¡A©Î¨«¸ô®Éªº¦w¥þ¡C
¥|¡B¤F¸Ñµê®zªÌªº»Ý¨D
¡@¡@«ü¾É¹B°Ê®Énª¾¹Dµê®zªÌ¦³¤°»ò¯S§O»Ý¨D¡A¦³¨Ç»Ý¨D©M¤U¦C¦]¯À¦³Ãö¡An¥[¥Hª`·N¡G1. ¯e¯fª¬ªp¡C2. ªA¥ÎÃĪ«¡C3. ·P©x¥\¯à³à¥¢ (¦pµøÄ±©Îťı¥\¯à¤£¨Î)¡C 4. »{ª¾¥\¯à¤£¨Î¡C5. ·¾³q§xÃø¡C6. ¯S§OÂåÀø³]³Æ (¦p®ñ®ð¨ÑÀ³)¡C7. ±¡ºü§xÂZ (¦pªq³à¡A»Ýn±¡ºü¤ä«ù)¡C8. ¨Åé²¾°Ê®É»Ýn¨ó§U¡C9. ¨ä¥L¡C
¤¡B±j½Õ¥þ¤H°·±d (wellness) ²z©À
¡@¡@¥þ¤H°·±d¥]¬A¨Åé¡B¤ß²z¡BªÀ·|¡B¾Ç²ß (»{ª¾)¡BÆF©Ê©MÀô¹Òµ¥¼h±ªº°·±d¡Aµê®z°ªÄ֪̦p¯à³W«ß¹B°Ê¡A¹ï¤Wz¦U¼h±°·±d¤§«P¶i¡A³£¦³«Ü¤jªº§U¯q (¤è¶i¶©¡A2015)¡A¦Ó¥þ¤H°·±dªº¨CÓ¼h±¡A¬Ò¬O¦¨¥\¦Ñ¤Æªºn¯À¡A¤]¬O¥¼¨ÓÅé¾A¯à²£·~µo®iªºÁͶաCÅé¾A¯à±Ð½m¦b¹B°Ê«ü¾É¹Lµ{¤¤¡A°£´£¤ÉÅé¾A¯à©Î¨Åé¥\¯à¥~¡A¤]nÝÅU¥þ¤H°·±d¨CÓ¼h±ªº´£¤É¡C
¤»¡B´î¤Ö¤[§¤®É¶¡
¡@¡@°ªÄÖ·|¼W¥[ÀRºA¥Í¬¡®É¶¡¡A¦Óµê®zªÌ§ó·|¦]¨Åé¥\¯à¤£¨Î¦Ó¼W¥[¤[§¤®É¶¡¡C¤[§¤·|¾ÉP¨Åé¥\¯à©M°·±dª¬ªpªº´c¤Æ¡A¦Ó¼W¥[¥¢¯à©M¦º¤`²v¡Cn¹ªÀyµê®zªÌ¦b§¤ª×¤@¬q®É¶¡«á¡A¦p¨C¤@Ó¤p®Én¯¸°_¨Ó¨«°Ê©Î±q¨Æ¨Å鬡°Ê¡C¦³¨Ç²³æ¨Å鬡°Ê¹ï©ó°·±d¦¨¦~¤H¨Ã¤£ºâ¤°»ò¡A¦ý¹ïµê®z¦Ñ¦~¤H´N¥i¥H§ïÅܥͬ¡¤è¦¡¡A¬Æ¦Ü§ïµ½°·±dª¬ªp©Î¨Åé¥\¯à¡C
¤C¡B¨Å鬡°Ê¿Ä¤J¥Í¬¡
¡@¡@³\¦h§ïµ½¨Åé¥\¯àªº¦³®ñ¹B°Ê¡Bªý¤O¹B°Ê¡B¥¿Å¹B°Ê©M¦ù®i¾Þµ¥¹B°Ê¡A¬Ò¥i¿Ä¤J¥Í¬¡¡A¯à°÷ÀH®ÉÀH¦a±q¨Æ³o¨Ç¬¡°Ê¡A®ÄªG·|§óÅãµÛ¡CÅé¾A¯à±Ð½mn«ü¾É°ªÄ֪̾Ƿ|³o¨Ç¬¡°Ê¡A¦Ó¯à©ó¥Í¬¡Àô¹Ò¤¤¦Û¤v¹ê¬I¡A¦p¨«¸ô´N¬O³Ì¦nªº¦³®ñ¹B°Ê¡G©Î¬O§Q¥Î¦Û¤v¨Å骺«¶q©Î²©ö¾¹§÷¡A´N¯à°÷±q¨Æªý¤O°V½m©Î¬O¥¿Å°V½m¡C
¤K¡B §Q¥ÎªÀ·|¸ê·½
¡@¡@³\¦h¤H¹ï©óµê®zªÌ¹B°Ê«O°·ªºª¾¯à¤F¸Ñ¤£¦h¡A¦Ó¥¢¥h¹B°Ê°Ê¾÷©Î§C¦ô¨Å鬡°Êªº«n©Ê¡C¥i§Q¥ÎªÀ·|¸ê·½¨ÓÀ°§Uµê®zªÌÁA¸Ñ¹B°Ê«O°·ª¾¯à¡C ºô¸ô¦³³\¦h°ê¤º¥~«Ü¦nªº°ªÄ֪̹B°Ê«ü¾É¼v¤ù¡A¥]¬A¦³®ñ¹B°Ê (¦p¨«¸ô)¡Bªý¤O¹B°Ê¡B¥¿Å¹B°Ê©Î¦ù®i¾Þµ¥¡A¦³¯¸µÛ¤]¦³§¤µÛªº¹B°Ê¤è¦¡¡A¦Ò¶q°ªÄ֪̪ºª¬ªp¡A¥i¿ï¾Ü¸û¬°Â²³æ©M½w©Mªº¹B°Ê¤è¦¡¡C§Ú¦b±Ð¾Ç®É¸g±`¤À¨É¤@¨Ç¾A¦X°ªÄ֪̪º¹B°Ê¼v¤ù (¦pYoutube¼v¤ù)¡A«Ü¦³³Ð·N¡B¦³½ì©M¿EÀy©Ê¡A¥i¹F¨ì¹B°Ê®ÄªG¡C¨ä¥L©|¥i°Ñ¦Ò¾A¦X°ªÄ֪̹B°Êªº«O°·®ÑÄy©Îºô¯¸¸ê®Æ¡A¹ï°ªÄ֪̪º¹B°Ê«ü¾É§¡¦³§U¯q¡C
¥î¡B¹B°Ê³B¤èªº³]p»P«ØÄ³
¡@¡@¹B°Ê³B¤èªº³]p»P«ØÄ³¡A¬ü°ê¹B°ÊÂå¾Ç·|©M¬ü°ê¤ßŦ¨ó·|°w¹ïµê®z°ªÄ̡֪A¦³¥H¤Uì«h©Êªº«ØÄ³ (ACSM, 2009)¡C1. °ªĄ֪̈C¶g¦Ü¤Ön±q¨Æ150¤ÀÄÁ¨Å鬡°Ê¡A ¦p¦]¬°¯e¯f©ÎÅé¯àª¬ªp¨S¿ìªk±q¨Æ150¤ÀÄÁ¡A¤]n¦b¥i¥H§Ô¨üªºª¬ªp¤U¬¡°Ê¨Åé¡AÁ×§KÀRºAªº¥Í¬¡¤è¦¡¡C2. µê®z¡B¨Åé¥\¯à¤£¨Î©Î¦³ºC©Ê¯e¯f¦Ñ¦~¤H¡A¶}©l¹B°Ê®É±j«×n§C¡A«ùÄò®É¶¡nµu¡C3. º¥¶it²üì«hn¦Ò¼{Ó§O®t²§¡A¿ï¾Ü°Ñ»PªÌ³ßÅwªº¹B°Ê¤è¦¡¡A¥B¦b¥i¥H§Ô¨üªºt²ü¤U¡A¥H¤ñ¸û«O¦uªº¤è¦¡¹B°Ê¡C4. µê®zªÌªºªý¤O°V½m©M¥¿Å°V½mn¦w±Æ¦b¦³®ñ¹B°Ê¤§«e¡C 5. ¦Ñ¦~¤Hªº¨Å鬡°Ê¶qnºCºC¼W¥[¡A¶W¹L³Ì°ò¥»«ØÄ³¶q¥H§ïµ½Åé¾A¯à©Î¨Åé¥\¯à¡C
¡@¡@¥»¤å°Ñ¦Ò¤Wzì«h©Ê«ØÄ³¡A´£¥X¨ãÅé©Ê¤§³]p¤Î«ØÄ³¦p¤U¡C
¤@¡B ¹B°Ê³B¤èªº³]p
¡@¡@¹B°Ê³B¤èªº³]p¡A°ò¥»¤W¦³¤Ó¨BÆJ¡A¥]¬A¡G1. ¹B°Ê«eªº¦w¥þµû¦ô (¥]¬A°Ý¨÷)¡C2. Åé¾A¯àÀË´ú¡C3. ¹B°Ê³B¤è³]p¡C4. ¹B°Ê³B¤è°õ¦æ¡C5. À˰Q×¥¿ (¤è¶i¶©, 2019)¡C²Ä1©M²Ä2Ó¨BÆJ¬On¤F¸Ñ°Ñ»PªÌªº¯e¯f¡B¯gª¬¡BªAÃÄ¡B¹B°Ê¡BÅé¾A¯à¡B°·±d©M¤é±`¥Í¬¡¤è¦¡µ¥ª¬ªp¡A¦³¤F³o¨Ç°ò¥»¸ê®Æ¡A¤~¯àÀ°°Ñ»PªÌ³]p¹B°Ê³B¤è¡A¨Ãµ¹¤©«ØÄ³¡C¹B°Ê«eªº¦w¥þµû¦ô¥i¥H°Ñ¦Ò¬ÛÃö¤åÄm (¤è¶i¶©, 2016)¡AÅé¾A¯àÀË´ú¥i¥H°Ñ¦Ò±Ð¨|³¡Åé¨|¸p°ªÄ֪̪ºÀË´ú¶µ¥Ø»P¤èªk¡A©Î°Ñ¦Ò«e¸`¤¶²Ðªº¤TºØ¨Åéªí²{¶µ¥Ø¡A¶i¦æ¥¿Å¡B¨«¸ô³t«×©M§¤¯¸®É¶¡ªº´úÅç¡C
¡@¡@¦¹¥~¡A¹B°Ê³B¤è©Îpµen¦Ò¶q¤Ó¦]¯À¡A¥]¬A¡G¹B°Ê¤è¦¡ (Mode)¡Bº¥¶it²ü (Rate of Progression)¡B¹B°ÊÀW²v (Frequency)¡B¹B°Ê±j«× (Intensity) ©M«ùÄò®É¶¡ (Time)¡C¦p¨ú³o¤¶µ¦]¯Àªº²Ä¤@Ó^¤å¦r¥À¡A«h¬°MRFIT¡uÅé¾A¯à¥ý¥Í¡v¡A¸û®e©ö°O¾Ð¡A¯÷±N¤Ón¯À»¡©ú¦p¤U¡C
¡@¡@(¤@) ¹B°Ê¤è¦¡¡G°ªÄÖµê®zªÌªº¹B°Ê¤è¦¡n¦h¤¸¡A¥Dn¹B°Ên¥]¬A¦³®ñ¹B°Ê¡Bªý¤O°V½m¡B¥¿Å°V½m©M¦ù®i¾Þ(¦pªí1)¡A¦hºØ¹B°Ê¤è¦¡ªº°V½m®ÄªG¤ñ³æ¤@¹B°Ê¤è¦¡¦n¡A¦]¬°¨CºØ¹B°Ê¤è¦¡¬Ò¦³¨ä¿W¯S©Ê¡A¥i¥H¤À§O¼W¥[¤ßªÍ¥\¯à¡B¦Ù¦×¾A¯à¡B¥¿Å¯à¤O©Î¬O¬X³n«× ¡C·íµM¦³¨Å鬡°Ê¤ñ¨S¦³¬¡°Ê¦n¡A¥®É¤]n¦h±q¨Æ¤é±`¬¡°Ê©Î®a°È¡A¥H¼W¥[¨Å鬡°Ê¶q¡C¦ý¶}©l¹B°Ê¶¥¬q¡Aµê®zªÌn¦Ò¶q¦Û¤vªº°·±d©MÅé¯àª¬ªp¡A¥i¥ý¿ï¾Ü¬Y¨Ç¹B°Ê¹ê¬I¡A¥¿Å¯à¤O¤£¨ÎªÌ¡An¥ý¶i¦æ¥¿Å°V½m¡A«á¦A³vº¥¥[¤J¨ä¥L¹B°Ê¤è¦¡¡A¦pªý¤O°V½m©Î¦³®ñ¹B°Ê¡C
¡@¡@(¤G) º¥¶it²ü¡G¨Åé«ö·Ó¥Î¶i¼o°h( Use or disuse)ªºì«h¹B§@¡A»Ýn¼W¥[t²ü¤~¯à³vº¥´£¤É¨Åé¥\¯à¡A¦Óµê®zªÌº¥¶it²üªºµ{«×n¤ñ¤@¯ë¥Á²³½wºC¡A¶}©lªº¹B°Ê±j«×n§C¡A®É¶¡nµu¡At²ü¼W¥[µ{«×¤]n¬Û¹ï¤Ö¡A¦p¸g¹L¤G¦Ü¤TÓ¬P´Á¦³®ñ¹B°Ê°V½m«á¡A¦Aµy·L¼W¥[¹B°Ê®É¶¡¡Aì«h¤W¤£¶W¹L1/10 (¦p¨C¤ÑºC¨«20¤ÀÄÁ¡A¸g¹L2-3¶g«á¡A¦A¼W¥[¨ì21-22¤À)¡C
¡@¡@(¤T) ¹B°ÊÀW²v¡GACSM¹ï©ó¦³®ñ¹B°Ê¡Bªý¤O°V½m¡B¥¿Å°V½m©M¦ù®i¾Þ°V½mÀW²v¦³¨ä¤£¦P«ØÄ³¡A¦³®ñ¹B°ÊÀW²v¤]ÀHµÛ¹B°Ê±j«×ªº¤£¦P¦Ó¦³©Ò½Õ¾ã¡A¦pªí1¡C ¦ý¶}©l¹B°Ê¶¥¬q¡Aµê®z°ªÄÖªÌn¨Ì¦Û¤vªº°·±d©MÅé¯àª¬ªp¦Ó°u¥H½Õ¾ã¡A¥i¥H§C©óACSM«ØÄ³ªºÀW²v¡Aµ¥¨Åé¥\¯à³vº¥§ïµ½«á¡A¦A¼W¥[°V½mÀW²v¡C
¡@¡@(¥|) ¹B°Ê±j«×¡Gµê®zªÌ¶}©l¹B°Ê®É±j«×n§C¡A¨Ì¾ÚACSM (2018) ªº¹B°Ê«e¦w¥þµû¦ô«ØÄ³¡A¦³¯e¯f©M¯gª¬¥B¨S¦³³W«ß¹B°ÊªÌ¡A»Ýn°·±d±M·~·ÓÅ@¤Hû¦P·N«á¡A¤~¯à±q¨Æ¹B°Ê¡A¤j³¡¤Àµê®zªÌÀ³ÄÝ©ó³oºØª¬ªp¡CACSMªº«ØÄ³¤]¾A¥Î©óµê®z¦Ñ¦~¤H¡A§Y¦b¦Û¤v¥i¥H§Ô¨ü(tolerated)ªºª¬ªp¤U¡A±q¨Æ§C¦Ü¤¤±j«×ªº¹B°Ê¡AµM«á¦A³vº¥¼W¥[t²ü (ACSM, 2018)¡C°ªÄÖµê®zªÌ«ØÄ³±Ä¥Î¹B°Ê¦Ûı¶qªíªº¬Û¹ï±j«×¡A¦p0-10ªº¦Ûı¶qªí¤¤¡A0¥Nªí«D±`»´ÃP¡A10¥Nªí«D±`¿E¯P±j«×¡A2-4ªí¥Ü§C±j«× (2- 3METs¡A»´ÃPºC¨«©Î±q¨Æ®a°È)¡A5-6ªí¥Ü¤¤µ¥±j«× (3-6 METs¦p¨«¸ô¡A¥i¥HÁ¿¸Ü)¡A7-8ªí¥Ü¿E¯P±j«× (>6 METs¡A¦pºC¶]¡AµLªkÁ¿¸Ü)¡C ªý¤O¹B°Êªº±j«×¥H¨CӰʧ@¥i°µ10-15¦¸¬°ì«h ¡A¬ù³Ì¤j¦Ù¤Oªº60-70%¡C¦³Ãö¦³®ñ¹B°Ê¡Bªý¤O°V½m¡B¥¿Å°V½m©M¦ù®i¾Þªº¹B°Ê±j«×°Ñ¦Òªí1¡C
¡@¡@(¤) «ùÄò®É¶¡¡G¶}©l¹B°Ê®É¡A³\¦hµê®z¦Ñ¦~¤H¥i¯àµLªk¨Ì¾ÚACSM«ØÄ³«ùÄò¹B°Ê30¤ÀÄÁ¡A¨S¦³Ãö«Y¡A´N¥Ñ¥®Éªº¹B°Ê°ò·Ç¶}©l¡A®É¶¡µu¤@ÂI¡A©Î¤À¬q¹ê¬I¦h¦¸¹B°Ê¡A²Ö¿n®É¶¡¡AÁö¨S¦³¹F¨ì«ØÄ³¹B°Ê®É¶¡¡A¥un¤ñ¥®É¼W¥[¹B°Ê®É¶¡¡A´N·|¦³¥¿±§ïµ½®ÄªG¡C¨Ì¾Úº¥¶it²üì«h¡A³vº¥¼W¥[¹B°Ê®É¶¡¡A¥un«ù¤§¥H«í¡A¾i¦¨³W«ß¹B°Ê²ßºD¡A´N¥i¥H¹F¨ì¬Æ¦Ü¶W¹L«ØÄ³¶q¡C¨CÓ¹B°Ê¤è¦¡ªº«ùÄò®É¶¡¦pªí1¡C
ªí1¡Gµê®z°ªÄ֪̦UºØ¹B°Ê³B¤èªº«ü¾Éì«h
¶µ¥Ø
©M
³B¤è | ¦³®ñ¹B°Ê | ªý¤O¹B°Ê | ¥¿Å¹B°Ê | ¦ù®i¾Þ |
| ¹B°Ê¤è¦¡ | ¨«¸ô¡BÃM¸}½ñ¨®¡B´åªaµ¥¡A¿ï¾Ü³ßÅw©M¤è«Kªº¹B°Ê | §Q¥ÎÅé«¡B°×¹a¡B¼u¤O±a¡B«°V¾¹§÷µ¥ | ¦h¤¸¹B°Ê
(¥]¬Aªý¤O°VÁå¡B¦UºØ¥¿Å°V½mµ¥) | °ÊºA©ÎÀRºA¦ù®i¾Þ |
| º¥¶it²ü | ºCºC¼W¥[t²ü
(®É¶¡¡B±j«×©MÀW²v) | ºCºC¼W¥[t²ü
(ªý¤O¡B¦¸¼Æ©Î¦^¦X) | ºCºC¼W¥[§xÃø«×
(§ïÅܤä«ù±¡B°Ê§@Ãø«×©Î·P©x§@¥Î) | ºCºC¼W¥[¦ù®i¬¡°Ê½d³ò |
| ¹B°ÊÀW²v | ¤¤µ¥±j«×¹B°Ê¨C¶g¦Ü¤Ö5¤Ñ¡A¿E¯P±j«×¹B°Ê¨C¶g¦Ü¤Ö3¤Ñ¡C | ¨C¶g¦Ü¤Ö2¤Ñ | ¨C¶g2-3¤Ñ | ¨C¶g¦Ü¤Ö2-3¤Ñ |
| ¹B°Ê±j«× | ¥Ñ§C¦Ü¤¤ªº±j«×¶}©l¡AµM«áºCºC¼W¥[¹B°Ê±j«×¡C
§Q¥Î¹B°Ê¦Ûı¶qªí¨M©w¬Û¹ï±j«× (¦p5-6¥Nªí¤¤µ¥±j«×) | ¤ÏÂЦ¸¼Æ10-15¦¸¡A60-70%³Ì¤j¦Ù¤O | ¾A«×¥¿Å§xÃø«×
(ÂǥѧïÅܤä«ù±¡B°Ê§@Ãø«×©Î·P©x§@¥Îµ¥¤è¦¡½Õ¾ã) | ¦ù®i¨ì¦³ÂI±i¤O¦ý¤£¯kµhªºµ{«× |
| «ùÄò®É¶¡ | ¤¤µ¥±j«×¹B°Ê¨C¦¸¦Ü¤Ö30¤ÀÄÁ | ¿E¯P±j«×¹B°Ê¦Ü¤Ö25¤ÀÄÁ | ¨S¦³©ú½T®É¶¡
(¨Ì°µ´XÓ¦^¦X©Î°Ê§@¦Ó©w)¡C | ¨C¦¸¬ù20-30¤À¡A¨CӰʧ@¦ù®i60¬í¡C¦p¨C¦¸20¬í«h°µ3¦¸ |
| ¨ä¥L | §Q¥Î¹B°Ê¦Ûı¶qªí§@¬°¹B°Ê±j«×¨Ì¾Ú | °V½m8-10Ó¥Dn¦Ù¦×¸s¡A¤@¦^¦X°V½m´N·|¦³®ÄªG¡C | ¨S¦³©ú½Tªº¹B°Ê³B¤è | ¨S¦³©ú½Tªº¹B°Ê³B¤è |
¤G¡B¹B°Ê³B¤èªº«ØÄ³
¡@¡@¤F¸Ñ¹B°Ê«ü¾Éªº¤@¯ëì«h©M¹B°Ê³B¤èªº³]p²z©À«á¡A¦³´XÓµê®zªÌ¹B°Ê³B¤è¬ÛÃöªº«ØÄ³¡A¥iÅý¹B°Êpµe§ó¬°¦³®Ä¡B¦w¥þ©M¦³½ì¡A´£¤É°Ñ»PªÌªº°Ê¾÷¡A¦Ó¦³§U©ó¾i¦¨¹B°Ê²ßºDªº¾i¦¨¡C
¡@¡@(¤@) «µø¨Åé¥\¯à¡G¤@¯ë¥Á²³¹B°Ê³B¤èªº¥Øªº¬O´£¤É°·±dÅé¾A¯à¡A¦Ó¹ï°ªÄÖµê®zªÌ«h¬O´£¤É¨Åé¥\¯à (Jones ¡® Rose, 2005; ¤è¶i¶©¡A2015)¡C¨Åé¥\¯à©M¤é±`¥Í¬¡¯à¤O¦³±K¤ÁÃö«Y¡A¥¢¥h¨Åé¥\¯à±NµLªk¿W¥ß¥Í¬¡¡A¥¦¥]¬A¤ßªÍ¥\¯à¡B¦Ù¤O¡B¦Ù@¤O¡B¥¿Å¡B³t«×¡B¨ó½Õ©M°Ê¤Oµ¥¡C¨Åé¥\¯à¤]¬O¨M©w¦¨¥\¦Ñ¤Æªº«n¦]¯À¡A·í¨Åé¥\¯à¥¢¥h®É¡A¤@Ó¤H´N¶}©lµê®z (Best-Martini & Jone-DiGenova, 2014)¡C¹B°Êpµen±j½Õ©M§ïµ½¨Åé¥\¯à¡A¤]nÅý°ªÄ֪̤F¸Ñ¨Å鬡°Ê¡B¨Åé¥\¯à»P¤é±`¥Í¬¡ªºÃö«Y¡CÁp¦X°ê½Ã¥Í²Õ´ (WHO) ©ó¥¼¨Ó¤Q¦~ (2020-2030) ±N±À°Ê°·±d¦Ñ¤Æ (Healthy aging) ²z©À¡A®Ö¤ß¬O´£¤É©Mºû«ù¨Åé¥\¯à(functional ability) ¦Ó¯à¨Ï¦Ñ¦~¤H¯à°÷¨É¨ü°·±d©¯ºÖ (wellbeing) ªº¹Lµ{ (WHO, 2015)¡C
¡@¡@(¤G) ÝÅU¥|¶µ¥Dn¹B°Ê¡Gµê®zªÌªº¹B°Êpµe¤º®en¥]¬A¦³®ñ¹B°Ê¡Bªý¤O¹B°Ê¡B¥¿Å¹B°Ê»P¦ù®i¾Þ¥|ºØ¹B°Ê¡A¤]¥i¿Ä¤J¬ÛÃöªº¹B°Ê¶µ¥Ø¡C¦Ò¶qÓ§O®t²§¡A§´µ½À³¥ÎÅé¾A¯à¥ý¥Í¡uMRFIT¡vªº«ü¾Éì«h¡A´N¯à´£¤É¨Åé¥\¯à¡C¹ï¤@¯ë¤H¦Ó¨¥¡A±q¨Æ¥±`¨Å鬡°Ê (¦p±q´È¤l¯¸¥ß©Î¬O³æ¸}¯¸¥ß) ¬O«Ü»´ÃPªº¡A¦ý¹ï©óµê®zªÌ´N¬O¤@Ө㦳¬D¾Ôªº°Ê§@¡A¤ÏÂйê¬I³o¨Ç²³æ°Ê§@´N¥i¥HÀò±o«Ü¦nªº°V½m®ÄªG¡C©Ò¥H«ü¾É¦Ñ¦~¤H³o¥|ºØ¹B°Ê¡An²³æ¤Æ©M¥Í¬¡¤Æ¡AÅýµê®zªÌÀH®ÉÀH¦a¬Ò¥i¹ê¬I¡C
¡@¡@(¤T) ±j½Õ¹B°Ê²ßºDªº¾i¦¨¡G¯à°÷Åýµê®z¾i¦¨¹B°Ê²ßºD©Î¬O°ÊºA¥Í¬¡¤è¦¡´N¬O¦¨¥\ªº¹B°Êpµe¡A°ß¦³«ùÄò¤£Â_¹B°Ê¡A¤~¯àºû«ù©Î§ïµ½¨Åé¥\¯à¡A§_«h¤¤Â_¹B°Ê¡A¨Åé¥\¯à¤]´N¸òµÛ°I°h¡C¦p¦óÀ°§Uµê®zªÌ¾i¦¨¹B°Ê²ßºD¬O¹B°Ê«ü¾ÉªÌn§V¤Oªº¤è¦V¡C¦b«ü¾Éµê®zªÌªº¹Lµ{¤¤¡A°£¤F±q¨Æ¨Å鬡°Ê©Î¹B°Ê°V½m¥~¡A¤]n§Q¥Î¦æ¬°§ïÅܪkªº²z½×»Pµ¦²¤¡A¼W¥[¨ä¹B°Ê°Ê¾÷¡B¦¨´N·P¡BºA«×©M¦Û§Ú®Ä¯à¡AÅý¥L̤F¸Ñ³W«ß¹B°Êªº«n©Ê¡AÄ@·N°Ñ»P¹B°Ê¡A¤]¦³¨¬°÷ªº§Þ¥©©Mª¾¯à¦b®a¸Ì¦Û§Ú¹B°Ê¡A¦Ó¾i¦¨¹B°Ê²ßºD©Î°ÊºA¥Í¬¡¤è¦¡¡C
¡@¡@(¥|) ª`·N¹B°Ê°V½m¶¶§Ç¡G«ü¾É©Î±a»âµê®zªÌ¹B°Ê®É¡A¨C¦¸¹B°Ên¥]¬A¼ö¨¡B¥Dn¹B°Ê¡B±Ð¨|¡B¥ð®§©M½w©M¹B°Êµ¥®É¬q¡A¬¡°Ê¤º®en°w¹ï°Ñ»PªÌªº°·±d»PÅé¾A¯àª¬ªp¡A¦Ò¶q©M¦w±Æ¤£¦Pªº½Òµ{¡A¦pªí2 (°Ñ¦ÒBest-Martini & Jone-DiGenova , 2014ªººc·Q)¡Cµê®zªÌ¦pªG¥®É¨S¦³¹B°Ê¡A°·±d©M¨Åé¥\¯àª¬ªp¤£¦n¡A¦p¦bªí2ªºµ{«×1¡A¥i¥ý±q¨Æ½wºCªº¼ö¨¡B¦ù®i¾Þ»P½w©M¹B°Ê¡A³vº¥¼W¥[¨Å鬡°Ê¶q¡C¦pªG¥¿Å¯à¤O¤£¨Î (ªí2ªºµ{«×2)¡A¶}©l¹B°Ê®Én¦w±Æ¥¿Å°V½m¡A¸g¹L¤@¬q®É¶¡°V½m«á¡A¨Åé¥\¯à»P°·±dª¬ªp§ïµ½«á¡A¦pªí2ªºµ{«×3¥H«á¡A¦A³vº¥¥[¤Jªý¤O°V½m¡C¦³®ñ¹B°Êµ¥¨ì¥¿Å¯à¤O©M¦Ù¦×¾A¯à¨ã¦³°ò¦¡A¤£®`©È¶^Ë«á¡A¦p¨ìµ{«×5¥H«á¡A¦A¹ê¬I¸û¬°¦w¥þ¡C
¡@¡@§¤µÛ¹B°Ê¸û¬°¦w¥þ¡Aµê®zªÌ¥i¥ý±q¨Æ§¤¦¡¦ù®i¾Þ¡B¥¿Å°V½m¡Bªý¤O¹B°Ê©M¦³®ñ¹B°Ê¡A³o¼Ë¸ûéw¡A¸û®e©ö¦b¥Í¬¡¤¤¹ê¬I¡A¤]¯à§ïµ½¨Åé¥\¯à¡A¦ÓÅýµê®zªÌ§ó¦³«H¤ßªº±q¨Æ¹B°Ê¡Cµê®zªÌ¨Åé¥\¯à³vº¥´£¤É«á (¦pµ{«×6)¡Aªý¤O¹B°Ê©M¦³®ñ¹B°Ê´N¦¨¬°¥Dn¹B°Ê¶µ¥Ø¡C¦b¹B°Ê¹Lµ{µê®zªÌn¦w±Æ¥ð®§©M¸É¥R¤ô¤Àªº®É¶¡¡A³o®É¥i¦w±Æ±Ð¨|®É¬q¡Aµ¹°Ñ»PªÌ¦^õX©M¹ªÀy¡A¤]n¤¶²Ð¦UºØ¹B°Ê¬ÛÃöªºª¾¯à¡A¥H´£¤É¹B°Ê¦Û§Ú®Ä¯à (self-efficacy)¡A¦pÁ¿¸Ñ³W«ß¹B°Ê¯q³B¡B¦p¦óÁ×§K¹B°Ê¶Ë®`©M¹B°Ê¥Í¬¡¤Æµ¥¤º®e¡A¦Ó§ïÅܹB°ÊºA«×¡A¾i¦¨¹B°Ê²ßºD¡A³o¬OÀ°§Uµê®zªÌ³Ì«nªº½ÒÃD¡C¤£ºÞ¥ô¦ó¦~ÄÖ¡A°·±dªºª¬ªp¦p¦ó¡A³z¹L¾A«×¨Å鬡°Ê³£¥i¥H§ïµ½¨Åé¥\¯à©M°·±dª¬ªp¡C
ªí2¡G¤£¦PÅé¯à»P°·±dµ{«×µê®zªÌªº¹B°Ê½Òµ{¦w±Æ¤º®e»P¶¶§Ç
| ½Òµ{¤º®e\Åé¯à°·±dµ{«× | 1 | 2 | 3 | 4 | 5 | 6 |
| ¼ö¨¹B°Ê»P¦ù®i | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ |
| ¥¿Å¹B°Ê | | ¡¯ | ¡¯ | ¡¯¡¯ | ¡¯ | ¡¯ |
| ªý¤O¹B°Ê | | | ¡¯ | ¡¯ | ¡¯ | ¡¯¡¯ |
| ¦³®ñ¹B°Ê | | | | | ¡¯ | ¡¯¡¯ |
| ½w©M¹B°Ê»P¦ù®i | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ |
| ¹B°Êª¾¯à±Ð¨| | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ |
| ³Ü¤ô»P¥ð®§®É¶¡ | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ | ¡¯ |
µù¡G¡¯¥Nªí±j½Õªº¶µ¥Ø¡A¡¯¡¯¥Nªí§ón¥[±jªº¶µ¥Ø¡C
µ{«×1-6¡A¼Æ¦r¶V°ªªí¥Ü¨Åé¥\¯à»P°·±dª¬ªp¶V¨Î¡C
¡@¡@(¤) ¹B°Ê³B¤è¬O¬ì¾Ç¤]¬OÃÀ³N¡Gµê®zªÌªº¹B°Êpµe»P«ü¾É¡A°£n°Ñ¦Ò¬ÛÃö¾Ç³N¾÷ºcªº«ü¾Éì«h©M¾Ç³N¬ìªºª¾¯à¥~¡A¤]n¦Ò¶qÓ§O®t²§»PÀô¹Òª¬ªp¡A°w¹ï¨äª¬ªp©M»Ýn³]p¾A·íªº¹B°Ê½Òµ{¡A©Ò¥H¨Ã¨S¦³©T©w¤£Åܪº°V½m½Òµ{©Î¤èªk¡C¦]¬°¹B°ÊºØÃþ«Ü¦h¤¸¡A¹B°Ê±j«×¡B®É¶¡©MÀW²v¤]¦³³\¦hÅܤƩM²Õ¦X¡A´x´¤«nªº«ü¾ÉªÌì«h©Mn»â¡A°V½m¤º®e¬O¥i¥H¦³«Ü¦h³Ð·N©MÅܤƪº¡C¥un¦³¤ßÄ@·N¾Ç²ß¡A¦b¸ê°T®É¥N¡A¨CÓ¤H¬Ò¥i¾Ç¨ì°ò¥»ªº¹B°Êª¾¯à¡A¦¨¬°¦Û¤v³Ì¨Îªº¹B°Ê±Ð½m¡A¤]¥i¥HÀ°§Uµê®zªÌ¹B°Ê¡A¤@°_¨É¨ü¹B°Ê¹Lµ{¡A¦@¦P´£¤É¨Åé¥\¯à©M°·±dª¬ªp¡C
³°¡Bµ²»y
¡@¡@¡u¹B°Ê´N¬O¨}ÃÄ¡A Exercise is Medicine¡vªº²z©À¥¿¦b¥@¬É¦U¦a¿n·¥±À°Ê¡A¹ªÀyÂå®v¯à±N¹B°Ê³B¤è·í§@±wªÌªvÀø¯e¯fªº¤@ºØ¤è¦¡¡A ¦Ó¡u°·±d¦Ñ¤Æ¡AHealthy aging¡vºc·Q±N©ó¦b2020-2030±À°Ê (WHO, 2015)¡AWHO§Æ±æ¨CÓ°ê®a¯à°÷ÀÀ©w©M±À°Ê¾A·í¬Fµ¦¡AÅý°ªÄ֪̺û«ùéw¥B¨}¦nªº¨Åé¥\¯à¡A¹LµÛ¦w¾Aªº±ß¦~¥Í¬¡¡C³o¨ÇÁͶնǹF¤@Ó«H®§¡A³W«ß¹B°Ê¬O¹w¨¾©Î§ïµ½¯e¯fªº«n¤èªk, ¤]¬O´£¤É¨Åé¥\¯àªºÃöÁä¡Cȱo¬Ù«äªº¬O¡A¤j³¡¤À°ªĄ֪̈S¦³³W«ß¹B°Ê©Î¹F¨ì¨Å鬡°Êªº«ØÄ³¶q¡C
¡@¡@¦Ñ¤Æ»P¨Å鬡°Ê¤£¨¬®e©ö°§C¨Åé¥\¯à»P°·±dª¬ªp¡A¦Ó¾ÉP¨Åé°I®z¡A¦p¨S¦³¾A«×§ïµ½¡A¦b¥¼¨Ó·³¤ë´N®e©öµo¥Í¶^Ë¡B¥¢¯à¡Bª×§É¡B¥Í¯f©M¦º¤`µ¥¨Æ¥ó¡A°ªÄ֪̦p¿©±wºC©Ê¯e¯f¡B¹B°Ê¶q¤£¨¬©Î¤ßªÍ¥\¯à¤£¨Î¡A³£·|¼W¥[³\¦hÂåÀø¤ä¥X©M¸ê·½ (¤è¶i¶©¡A2019)¡C¥Í¦Ñ¯f¦ºÁö¬O¦ÛµM²{¶H¡A¦b¥Í©Rªº¥½´Á¡A¦º¤`¤]¤£¥i©È¡A³Ì¥i©ÈªºÀ³¬Oªø®É¶¡ª×§É¡A¨ü¨ì³\¦hºØºC©Ê¯e¯fªº§éÄË¡A¦Û¤vµhW¡A¤]Åý®a¤H¸òµÛ¨üW¡C
¡@¡@¶W°ªÄ֮ɥN§Y±N¨ÓÁ{¡A¨ì2026¦~¡A¥xÆW65·³¥H¤W¤H¤f·|¶W¹L 20% (¤º¬F³¡²Îp³B¡A2018)¡A±¹ï°ªÄÖªÀ·|©Ò±a¨ÓªººC©Ê¯e¯f¡B¥Í¬¡«~½è»PÂåÀø¸ê·½µ¥½ÄÀ»¡A½Ã¥ÍºÖ§Q³¡¥Ø«e¥¿¿n·¥±À°Êªø·Ó2.0pµe¡A°ê¥Á°·±d¸p¤]©ó108 ¦~±À¥X¡u¹w¨¾°I®zªA°Èºô-¼Ï¯Ãpµe¡v¡A·þ«P¦U¦a½Ã¥Í§½©Ò¥²¶·³sµ²¦U¦a¸ê·½¡A¿n·¥§ë¤J¬ÛÃöªA°Èªº§ï³y¡C¥Ø«e¥xÆW¤w¦³³¡¤À¿¤¥«½Ã¥Í§½¶}©l±À°Ê¡A¦p¹ü¤Æ¿¤½Ã¥Í§½¦b½Ã¥Í©Ò±À°Êªº¡u¤£¦Ñ°·¨§{¡v¡A¹ªÀyªÀ°Ï°ªĄ֪̈ì½Ã¥Í©Ò¹B°Ê¡C´Á¬ß³o¨Ç¹w¨¾°I®zªº¬ÛÃöpµe¡A¯à°÷¿Ä¤J¦³®Äªºµ¦²¤»P¤èªk¡A§ïµ½°ªÄ֪̪ºµê®z¯gª¬¡A³yºÖ¥Á²³¡C
¡@¡@¥»¤å°Ñ¦Ò°ê¤º¥~¬ÛÃö¤åÄm¡A°w¹ï¨Åé°I®zªºµû¶q¤èªk¡B¹B°Ê¯q³B¡B¹B°Ê«ü¾Éì«h©M¹B°Ê³B¤è¡A¾ã²z¥X¤@¨Ç¸û¬°¨ãÅé©M¹ê¥Îªº¸ê®Æ¡A´£¨ÑŪªÌ©M¬ÛÃö±M·~¤H¤h°Ñ¦ÒÀ³¥Î¡A§Æ±æ¯à¯u¥¿À°§U°ªÄÖµê®zªÌ¾i¦¨¹B°Ê²ßºD¡A¨É¨ü¨Å鬡°Ê¹Lµ{¡A¤]¦b¹B°Ê¤¤Åé·|°·±d©M¥Í©Rªº¬ü¦n¡A¨É¨ü¡u°·±d¦Ñ¤Æ¡v©Î¡u¦¨¥\¦Ñ¤Æ¡vªº¥Í¬¡¡C
°Ñ¦Ò¤åÄm
¤è¶i¶© (2019)¡C¨Å鬡°Ê¡BÅé¾A¯à»PÂåÀø¸ê·½¡C¹B°Ê¥Í²z¶g°T¡A394¡C
http://www.epsport.net/epsport/week/show.asp?repno=394
¤è¶i¶© (2019)¡C¹B°Ê³B¤è (¤Gª©)¡C¥x¥_¥«¡GµØ³£¡C
¤è¶i¶© (2016)¡C¹B°Ê«eªº¦w¥þµû¦ô-2015¦~ACSMªº·s«ØÄ³¡C¹B°Ê¥Í²z¶g°T¡A338¡Chttp://www.epsport.idv.tw/epsport/week/show.asp?repno=338
¤è¶i¶© (2015)¡C°ªÄ֪̪º¹B°Ê»P¥þ¤H°·±d¡C¥x¥_¥«¡GµØ³£¡C
¤º¬F³¡²Îp³B (2018)¡Chttps://www.moi.gov.tw/stat/news_detail.aspx?sn=13742¡C
½Ã¥ÍºÖ§Q³¡°ê¥Á°·±d¸p (2019)¡C108¦~¹w¨¾°I®zªA°Èºô¡X¼Ï¯Ãpµe¡Ï¸É§U§@·~¥Ó½Ð¡Cfile:///Users/t08026/Downloads/108¦~¹w¨¾°I®zªA°Èºô-¼Ï¯Ãpµe+¸É§U§@·~¥Ó½Ð¶·ª¾ (2).pdf
American College of Sports Medicine (2018). ACSM's guidelines for exercise testing and prescription (10th ed.). Philadelphia: Lippincott Williams & Wikins.
American College of Sports Medicine (2009). Exercise and physical activity for older adults, position stand. 0195-9131/09/4107-1510/0MEDICINE & SCIENCE IN SPORTS & EXERCISE. https://insights.ovid.com/crossref?an=00005768-200907000-00020
American Heart Association (2007). Physical activity and public health in older adults: recommendation from the ACSM and American Heart Association. Medicine and Science in Sports and Exercise, 39(8), 1435-1445.
Best-Martini, E., & Jone-DiGenova, K. A. (2014). Exercise for Frail Elders (2nd ed.). Campaign, IL: Human Kinetics.
Chang, C. I., Chan, D. C., Kuo, K. N., Hsiung, C. A. & Chen, C. Y. (2011). Prevalence and correlates of geriatric frailty in a northern Taiwan
community. Journal of Formos Medicine Association. 110, 247-257.
Chodzko-Zajko, W. J., Proctor, D. N., Fiatarone Singh, M. A., Minson, C. T., Nigg, C. R., Salem, G. J., & Skinner, J. S. (2009). Exercise and physical activity for older adults. Medicine and Science in Sports and Exercise, 41(7), 1510 -1530.
Collard, R. M., Boter, H., Schoevers, R. A. & Oude Voshaar, R. C. (2012). Prevalence of frailty in community-dwelling older persons: a systematic review. Journal of the American Geriatrics Society. 60, 1487-1492.
Fried, L. P., Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., & McBurnie, M. A. (2001). Frailty in older adults: evidence for a phenotype. Journal of Gerontology: Medical Science. 56A(3), M146-156.
European Medicines Agency Committee for Medicinal Products for Human Use, Reflection paper on physical frailty: instruments for baseline characterisation of older populations in clinical trials, 9 January 2018. https://www.ema.europa.eu/en/physical-frailty-instruments-baseline-characterisation-older-populations-clinical-trials
Haider, S., Grabovac, I., & Dorner, T. E. (2019). Effects of physical activity interventions in frail and prefrail community-dwelling people on frailty status, muscle strength, physical performance and muscle mass - a narrative review. Wien Klin Wochenschr, 131, 244-254.
Jones, C. J., & Rose, D. J. (2005). Physical Activity Instruction of Older Adults. Champaign, IL: Human Kinetics.
Liao, Y. Y., Chen, I. H., & Wang, R. Y. (2019). Effects of Kinect-based exergaming on frailty status and physical performance in prefrail and frail elderly: A randomized controlled trial. Scientific Reports
, Article number: 9353.
Spirduso, W., Francis, K., & MacRae, P. (2005). Physical Dimensions of Aging (2nd ed.). Campaign, IL: Human Kinetics.
U.S. Department of Health and Human Service. (2018). Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: U.S. Department of Health and Human Service.
World Health Organization. (2015). what is healthy ageing. Global Health and Aging. Retrieved from https://www.who.int/ageing/healthy-ageing/en/
Verghese, J., & Xue X. (2010). Identifying frailty in high functioning older adults with normal mobility. Age Ageing, 39, 382-385.
WHO (2015). What is Healthy Aging? https://www.who.int/ageing/healthy-ageing/en/